Board of Directors
Dr. Chia-Nan Chen
Chairman of the Board / President
In 2013, Dr. Chen, was one of the founders of GNTbm and served as a board member and the President. Since 2016, he has served as the Chairman of the Board/ President. Dr. Chen studied pharmacy, passed the national examination and is a pharmacist. He conducted further study and focused on research in the fields of chemistry, biochemistry, and molecular biology. He received his Ph.D. in Biochemistry and Molecular Biology in 2004 from the College of Medicine at National Taiwan University and then joined the National Health Research Institutes (NHRI, Taiwan) as a postdoctoral fellow. After his postdoctoral training, Dr. Chen moved into industry, where he served as the Vice President of Research and Development for NatureWise Biotech and Medicals Corporation, which is mainly engaged in the development of new drugs, and then as the Vice President and President in GNT Inc. Now, Dr. Chen is the Chairman of the Board and the President of GNTbm. Dr. Chen is devoted to the development of epigenetic modulators, tumor microenvironment regulators, epigenetic immunoactivators, and immunoregulatory multi-kinase inhibitors in cancer immunotherapy field. He has applied for, and been awarded, invention patents overseas for more than 15 projects, and has published more than 20 scientific articles in international journals. Dr. Chen’s biggest passion is to develop new drugs to satisfy the unmet needs of advanced cancer patients.
Mr. Hung-Jen Wu
Director of the Board
Mr. Hong-Jen Wu was a former President and board member of United Microelectronics Corporation (UMC), as well as the President of the Nippon Foundry Inc. (NFI). He is now the board member of various technology and biotech companies. Mr. Wu graduated from the Department of Chemical Engineering and the Graduate Institute of National Development at the National Taiwan University. He is highly experienced in industrial development and administrative planning.
Dr. Chung-Yang Huang
Director of the Board
Dr. Chung-Yang Huang graduated from the Department of Pharmacology in the College of Medicine, National Taiwan University, and holds a BS in Pharmacology from the University of Ohio, USA, and an MBA from Case Western Reserve University, USA. He received a Ph.D. in Cellular Biology from the Institute of Life Sciences at Lanzhou University, China. Before returning back to Taiwan, he served as Vice President of DDM Pharmaceuticals (USA) and President at IPS Pharmaceuticals. After returning to Taiwan, Dr. Huang established NatureWise Biotech & Medicals Corp. He was also a former board member and President of the listed company PhytoHealth Corporation. Dr. Huang is highly experienced in the field of new drug development and now serves as Chairman of Board and President in NatureWise Biotech & Medicals Corp.
Mr. Gary T. Tseng
Director of the Board
Mr. Gary T. Tseng assumed the position of director of the board of GNTbm on May 14, 2021. He mainly used his relevant experience to help the company grow and thrive in all aspects. Mr. Gary T. Tseng 's major education is National Taiwan University, School of Management: Degree of MBA (Jan.2005)、Harvard University, John F. Kennedy School of Government: Diploma, Program for Senior Executives in National and International Security (Aug.2003)、National Chengchi University, Graduate Institute of International Law and Diplomacy: Degree of Master of Diplomacy and International Relations (1982), and his main experience is Trainee Reporter, United Daily News (1983)、Lecturer of International Relations, Shih Hsin College (1984-1986)、Chief News Liaison Official, Information and Cultural Affairs Department, MOFA (also serving as secretary to the spokesman) (1984-1986)、Secretary (Deputy Consul, Consul), Taipei Trade and Economic Representative Office in Chicago (Consulate General in Chicago) (1985-1995)、Counselor and Chief Protocol Official, Taipei City Government (1995-1999)、Director, Secretary Department, Management Board, Public Service Pension Fund, Ministry of Civil Service (1999-2000)、Director General, Department of Special Affairs, Office of the President (2000-2006)、Secretary to the President, Office of the President (2006)、Vice Chairman, TAITRA (2006-2008)、Deputy Chairman, TTY Biopharm (2008~2018).
Dr. Johnsea Chen
Independent Director
Currently, Dr. Chen is the Chairman and CEO of CMSC, Inc. in Hsinchu Science Park, Taiwan. In that role, he leads CMSC’s business growth and globalization. He is also a board member and co-founder of Art Analog, Inc., which is headquartered in Hsinchu Science Park and operates a wholly owned subsidiary in Kanagawa, Japan. Art Analog’s core competence is in the area of precision analog IC design and commercialization with the contribution from an experienced IC design team in Japan. Previously, Dr. Chen was the President and COO of Cadence Methodology Service Corporation, a wholly owned subsidiary of Cadence Design Systems. Cadence is a pivotal leader in electronic design automation. He led Cadence Methodology Service Corporation R&D team, new business incubation, partnerships, and restructuring. With the support from Vanguard International Semiconductors and China Investment and Development Corporation Dr. Chen drove Cadence Methodology Service Corporation’s restructuring process from a Cadence subsidiary into a local entity in Taiwan. Prior to joining Cadence, Dr. Chen served as Chief Operation Officer and Spokesman of Etron Technology, Inc., a specialty memory IC company. He also supported and carried out corporate strategy development of Etron in business expansion and investment. Prior to Etron, Dr. Chen was a Co-founder, Board Member and President of Hexawave Photonics, Inc., an IDM company founded in 1991 with core technology in GaAs compound semiconductor. During Dr. Chen’s six-year career at Rockwell International, Science Center, located in Thousand Oaks, California, he was responsible for the research and development of a special compound semiconductor material which was an essential part of infrared night vison system. Dr. Chen received his Ph.D. Material Science from the University of Southern California in 1985 and BS degree in Material Science & Engineering from National Tsing Hua University in 1977.
Mr. Hung-hui Cheng
Independent Director
Mr. Hung-Hui Cheng is the founder of Mingda CPA firm and a practicing CPA in Taiwan with broad experiences. Mr. Cheng has experiences in serving Taiwan public-listed companies and famous multi-national companies, like Metlife Insurance, Shin-Kuang Life Insurance, Askey Computer, Nike, TNT, J&J, etc. Mr. Cheng is also the independent director of Keding Enterprise and Prudential Life Insurance Company of Taiwan. Mr. Cheng receives his master degree and bachelor degree with accounting major from National Taiwan University, and LLM degree from National Chengchi University. Mr. Cheng holds Taiwan CPA, US and Australia licenses, and CIA (Certified Internal Auditors) license.
Dr. Shang-Pwu Shia
Independent Director
Dr. Shang-Pwu Shia graduated from the University of Texas with a Ph.D. in molecular cell biology. He had held research positions at the UT Southwestern Medical Center and the James Cancer Hospital Research Center at Ohio State University. Dr. Shia had also served with companies such as Beckman Instruments Co., F-J Instruments Co. and Media Cybernetics. After that, Dr. Shia entered the Development Center for Biotechnology and established the NanKang Biotechnology Incubation Center and served as the director. In the meantime, Dr. Shia also participated the training programs of MOEA Multidisciplinary Management of Technology, Asia Pacific Legal Institute, Washington University Business School Multidisciplinary Entrepreneur, and Peking University International Intellectual Property Research Center Science and Technology Management. Dr. Shia is currently the chairman of the Chinese Intellectual Property Trade Association, the convener of the Biotech Industry Group of the Chinese International Investment and Finance Association, government projects review committee, business consultant, and tutor for start-ups.
Ms. Hsiu-Chen Chiu
Independent Director
Hsiu-Chen Chiu is a senior lawyer with rich professional experience and excellent academic background. She is licensed to practice law in Taiwan and mainland China and has a patent attorney license. Independent director Chiu has a doctorate degree in law from Tsinghua University in mainland China and a master's degree in law from National Chengchi University. In addition, she also went to the Institute of International Business Strategy, Hitotsubashi University, Japan as a visiting scholar.
